SLN
Silence Therapeutics Plc American Depository Share
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
SLN Stock Analysis: Buy, Sell, or Hold?
$19.80
+0.03 (+0.15%)
â˛
5d:
+0.41%
30d:
+120.49%
90d:
+44.31%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (37%)
Quality Score
42/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$10.42 â $20.41
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-52.0x
Next 12M consensus est.
Wall Street Target
$19.75
-0.1% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$19.70 / $19.82
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: SLN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When SLN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SLN is currently trading at $19.80, which is considered slightly high relative to its 30-day fair value range of $10.42 to $20.41.
Technical Outlook: Technically, SLN is in a strong uptrend. The price is currently testing key support at $19.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SLN scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SLN is in a strong uptrend. The price is currently testing key support at $19.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SLN scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$10.42 -
$20.41
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
36.8%
Trading Range & Key Levels
30-Day Trading Range
$10.42 -
$20.41
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$19.70
Resistance Level
$19.82
Current Trend
Strong Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($19.75)
- WARNING: Composite score 42/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-52.03
Wall Street Target
$19.75
(-0.1%)
Revenue Growth (YoY)
197.2%
Share SLN Analysis
Share this live SLN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 12, 2026 2:45 PM ET
Data refreshes hourly during market hours. Next update: 3:45 PM
Data refreshes hourly during market hours. Next update: 3:45 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 52 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 52 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 37 SELL |
|
ARWR
Arrowhead PharmaceuticalâĻ |
STRONG BUY
15 analysts |
$108 | 50 HOLD |
|
ZYME
Zymeworks Inc. Common StâĻ |
STRONG BUY
14 analysts |
$42 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SLN Research Pages
